Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error

Fertil Steril. 2003 Jul;80(1):34-42. doi: 10.1016/s0015-0282(03)00556-9.

Abstract

Objective: To compare the effects of the contraceptive patch to oral contraceptives (OCs) on follicular size and incidence of ovulation in normal cycles and after dosing errors.

Design: Randomized, open-label.

Setting: Twelve centers.

Patient(s): One hundred twenty-four ovulatory women.

Intervention(s): Subjects received either the patch (groups 1 and 2) or one of three OCs. Correct dosing occurred in cycles 1, 2, 3, and 5. The following dosing errors were planned during cycle 4, a shortened 10-day cycle: [1] patch group 1 subjects wore one patch for 10 consecutive days; [2] for patch group 2 and OC subjects, 7 dosing days were followed by 3 drug-free days.

Main outcome measure(s): Follicular size, as determined at each cycle by the maximum mean follicular diameter.

Result(s): After a 3-day dosing error, follicular size was significantly smaller in the patch group (mean, 7.0 mm) vs. each OC group (range of means, 11.8-17.1 mm). Similar results were seen after proper dosing. The incidence of ovulation was significantly lower for the patch users than for women using OCs.

Conclusion(s): Follicular size and incidence of ovulation were significantly reduced among contraceptive patch users compared with women using OCs in normal cycles and after planned dosing errors.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Administration, Oral
  • Adolescent
  • Adult
  • Contraceptive Agents, Female / administration & dosage
  • Contraceptive Agents, Female / pharmacology*
  • Contraceptives, Oral, Combined / administration & dosage
  • Contraceptives, Oral, Combined / pharmacology*
  • Contraceptives, Oral, Hormonal / administration & dosage
  • Contraceptives, Oral, Hormonal / pharmacology*
  • Drug Combinations
  • Estradiol / blood
  • Estradiol Congeners / administration & dosage
  • Estradiol Congeners / pharmacology*
  • Ethinyl Estradiol / administration & dosage
  • Ethinyl Estradiol / pharmacology*
  • Ethisterone / analogs & derivatives
  • Female
  • Follicle Stimulating Hormone / blood
  • Humans
  • Luteinizing Hormone / blood
  • Medication Errors
  • Norgestrel / analogs & derivatives
  • Ovarian Follicle / diagnostic imaging
  • Ovarian Follicle / drug effects*
  • Ovarian Follicle / physiology
  • Ovulation / drug effects*
  • Ovulation / physiology
  • Oximes
  • Progesterone / blood
  • Ultrasonography

Substances

  • Contraceptive Agents, Female
  • Contraceptives, Oral, Combined
  • Contraceptives, Oral, Hormonal
  • Drug Combinations
  • Estradiol Congeners
  • Oximes
  • Norgestrel
  • Ethinyl Estradiol
  • Progesterone
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Ethisterone
  • norelgestromin